Use of gabapentin with or without a prescription in substance use treatment settings: A national analysis of urine drug testing data, 2016-2023.  Ellis MS, Whitley P, Passik SD.  Drug Alcohol Depend. 2026 Feb 1;279:113020. doi: 10.1016/j…

Medicinal use of non-prescribed cannabis: a cross-sectional survey on patterns of use, motives for use, and treatment access in the Netherlands.  Strada L, Korteling S, Vergeer M, Oomen P.  J Cannabis Res. 2025 Dec 2. doi: 10.1186/s42238…

Health, Costs, and Injection-Related Infections at a Hypothetical Overdose Prevention Center.  Padmanabhan P, Tin Y, Nall SK, et al.  JAMA Netw Open. 2026;9(1):e2555965. doi:10.1001/jamanetworkopen.2025.55965 https://jamanetwork.com/jou…

Retention on Buprenorphine for Opioid Use Disorder in Justice-Involved Individuals: A Retrospective Cohort Study.  Yatsco A, Vega FR, Cohen AS, Cardenas-Turanzas M, Langabeer JR, Champagne-Langabeer T.  Behav Sci (Basel). 2026 Jan 15;16(…

Schottland. SDF – Scottish Drugs Forum - SDF Learning Centre High-quality, evidence-based training designed to inform, support, and empower anyone engaging with people affected by substance use. (aufgerufen am 19.02.2026) https://sdflearningcentre…

The Polysubstance Assessment Tool: Reliability, acceptability and feasibility of a novel measure of polysubstance use.  Bunting AM, Cleland CM, Barratt SM, Griffin B, Williams J, Oser CB, et al. Addiction. 2026…